CompletedPhase 4ketamine

Ketamine on Acute Pain in Females and Males

NCT ID

NCT00232492

Target Enrollment

128 participants

Start Date

2005-01

Est. Completion

2006-11

About This Study

The purpose of the study is to determine whether equal subanesthetic doses of racemic ketamine is equally effective on females and males after surgical removal of third molars

Conditions Studied

Mouth and Tooth DiseasesTooth, Impacted

Interventions

•Placebo males
•Ketamine 0,1 mg/kg males
•Ketamine 0,3 mg/kg males
•Ketamine 0,5 mg/kg males
•Placebo females
•Ketamine 0,1 mg/kg females
•Ketamine 0,3 mg/kg females
•Ketamine 0,5 mg/kg females

Eligibility

Age:20 Years - 30 Years

Healthy Volunteers:No

View full eligibility criteria

Inclusion Criteria:

* Indication for removal of third molar
* Between 20 and 30 years of age
* ASA Class 1

Exclusion Criteria:

* Psychiatric family (father/mother) or own anamnestic history
* Hypersensitivity towards NSAIDS or other rescue analgesics
* Verified or suspected pregnancy
* Lactating females
* Surgery lasting over 60 min

Study Locations (1)

Department of Oral and Maxillofacial Surgery, Ullevaal University Hospital

Oslo, Norway